sana: the income statement

MyFinsight

Sana Biotechnology, Inc. (SANA)

For the quarter ending 2025-06-30, SANA made $1,175K in revenue. -$93,800K in net income. Net profit margin of -7982.98%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Other income (expense), net	598
Research and development	29,761
General and administrative	10,341
Impairment of long-lived assets	44,611
Research and development related success payments and contingent consideration	10,262
Total operating expenses	94,975
Loss from operations	-94,975
Interest income, net	577
Net loss	-93,800

Basic earnings (loss) per common share	-0.39
Diluted earnings (loss) per common share	-0.39
Weighted-average number of common shares - basic	238,409,000
Weighted-average number of common shares - diluted	238,409,000

Unit: Thousand (K) dollars (except for numbers of shares and EPS)